calcium, the investigators in this study detail three criteria by which a candidate protein could be classified as a SOAF: microinjection of the recombinant protein into an oocyte mimics oocyte activation induced by intracytoplasmic sperm injection, relevant antibodies and/or competitive peptides block sperm-induced egg activation, and the candidate protein resides in the postacrosomal sheath subcompartment of the sperm perinuclear theca. This study is a further examination of these criteria.
In their recent publication, Aarabi et al. 3 focused on PAWP as a major SOAF responsible for calcium oscillations occurring in oocytes after activation. The authors confirmed their previous findings in Xenopus and porcine systems by demonstrating that PAWP also triggers calcium oscillations and pronuclear formation in human and mouse oocytes. They found that expression of recombinant PAWP protein in oocytes mimics egg activation initiated by intracytoplasmic sperm injection.
To provide further evidence that PAWP acts as a SOAF, sperm-induced calcium oscillations were blocked by co-injection of a competitive inhibitor peptide derived from the WW domain-binding motif of PAWP. A significant advancement that this manuscript offers is that these studies are the first to show a candidate protein that successfully fulfills all three criteria required for a protein to be accurately classified as a SOAF. Specifically, PAWP is present in the perinuclear theca of the sperm and is present in elongating spermatids. 10 This ensures that the protein is deposited into the ooplasm at fertilization. We would also like to draw attention to the eloquent experimentation showing inhibition of the sperm-induced calcium oscillations by PAWP competitive peptides. When PAWP is blocked by competitive inhibition in human or mouse oocytes, activation fails to initiate, indicating a potential dominant role for PAWP in egg activation and subsequent embryo development.
Aarabi et al. 3 discuss the potential of treating male infertility using a synthetic version PAWP. The research is promising for the diagnosis and treatment of male factor infertility cases where a patient's spermatozoa are unable to initiate or induce activation of the egg to form an early embryo. Regardless of whether PAWP is the sole SOAF, these findings may provide clinicians with a therapeutic approach for egg activation in cases where intracytoplasmic sperm injection alone is not sufficient to activate the egg.
Further investigations need to be performed to decide more definitively if PAWP is an essential SOAF and whether it acts in concert with other factors to elicit calcium oscillations and oocyte activation. For example, future experiments should determine if the PAWP competitive peptides interfere the egg activation observed by others with PLCζ. It will also be important to ascertain whether the mice nullizygous for the Wbp2nl gene exhibit an infertile phenotype and, if so, at what level of the reproductive process the defect appears (e.g., egg activation or earlier steps). Finally, these studies produced the recombinant PAWP protein within the egg from cRNA, a method whereby it is difficult to control the levels of protein expression. Although it is technically demanding to do so, studies to characterize a SOAF should determine the amount of the candidate protein in a single sperm and demonstrate that microinjection of an equivalent quantity into an unfertilized egg is sufficient for activation.
The studies by Aarabi et al. 9 emphasize the importance of understanding the molecular mechanisms of infertility. Although idiopathic infertility can oftentimes be overcome by intracytoplasmic sperm injection, this is not always the case. The authors of this manuscript have recently shown a correlation between PAWP levels in sperm and fertilization rates in humans. 9 Low levels of PAWP in sperm as detected by immunofluorescence and flow cytometry resulted in decreased rates of normal embryonic development after intracytoplasmic sperm injection. These studies indicate a need for a better understanding of the molecular mechanisms underlying male infertility. This clarity could result in drug discovery to treat couples suffering from idiopathic infertility as well as help identify targets for male contraception. The studies detailed in this manuscript represent very important steps forward in our understanding of egg activation. Here we discuss these new findings and examine the evidence suggesting PAWP as the "real" sperm factor.
M ammalian embryo development i s i n i t i ate d b y i n t r a c e l l u l a r
At fertilization, the first event following the fusion of sperm and oocyte membranes is a series of transient rises in the intracellular-free Ca 2+ concentration, termed Ca 2+ oscillations.
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Over the past decade, mounting experimental and clinical evidence has been congruent with the hypothesis that the sperm factor responsible for the initiation of Ca 2+ oscillations during mammalian fertilization is a testis-specific isoform of PLC-zeta (PLCζ). [4] [5] [6] [7] [8] Since the discovery of PLCζ in 2002, many research laboratories across the world ( Table 1) have reported experimental evidence compatible with the proposition that PLC, termed PLCζ is the sperm factor that causes Ca 2+ oscillations at fertilization. Based upon numerous complementary studies, the current The recent FASEB Journal paper by Aarabi et al. 9 reports that PAWP, a sperm head protein that exclusively resides in the postacrosomal sheath region of the perinuclear theca, is able to produce Ca 2+ oscillations and pronuclear formation in human and mouse oocytes similar to what is observed during intracytoplasmic sperm injection. This group previously identified PAWP 10 as an alkaline-extractable protein with sequence homology to the N-terminal half of WW domain-binding protein 2, while the C-terminal half is rich in proline residues. Aarabi et al. 9 also report that sperm-induced Ca 2+ oscillations are blocked by co-injection of a competitive peptide inhibitor, derived from the WWI domain-binding motif of PAWP. This implies there is a requirement for PAWP binding to an oocyte-derived protein for successful fertilization to occur (Figure 1, right side) .
The recent indication of PAWP-induced Ca 2+ signalling 9 in oocytes comes 7 years after this group's initial data showing that PAWP promotes meiotic resumption and pronuclear development during fertilization. 10 Based on their studies, microinjection of PAWP protein into porcine, bovine, macaque, and Xenopus oocytes resulted in pronuclear formation, an indicative event of successful oocyte activation. 10 However, to date, no other research groups have independently verified PAWP's ability to activate oocytes and/or cause Ca 2+ oscillations. Recently, we have investigated whether mouse PAWP can initiate Ca 2+ oscillations and oocyte activation in the mouse. 11 We microinjected into mouse oocytes the recombinant mouse PAWP protein, or the complementary RNA encoding either untagged PAWP, or YFP-PAWP, or PAWP-luciferase, but we consistently failed to observe any Ca 2+ increases. In addition, PAWP was unable to hydrolyse PIP 2 in vitro and also did not act as a generic activator of PLC activity. 11 To the best of our knowledge, this is the first attempt to independently confirm the key findings on PAWP by the Oko group, but we could not verify that PAWP has any ability to mobilize intracellular Ca 2+ or activate mouse oocytes. Aarabi et al. 9 also state that PAWP and an oocyte-derived WWI domain protein substrate is required for successful fertilization, because sperm-induced Ca 2+ oscillations were blocked by co-injection of a 16-amino acid proline-rich peptide, derived from the PAWP WWI domain binding motif. Interestingly, the negative control peptide that was used had only a single amino acid substitution (Tyr/Phe) and this did not affect the sperm-induced Ca 2+ oscillations in oocytes.
The results with these PAWP peptides has led to the hypothesis that PAWP mediates its effects in oocytes via interaction with other proteins, such as the yes-associated protein, that may then lead to activation of PLCγ. However, previous studies using SH2 domain-derived peptides have suggested that PLCγ does not mediate Ca 2+ oscillations in fertilizing mouse oocytes. 12 Hence, if PAWP mediates any potential effects via PLCγ, then its precise role in physiological activation during fertilization remains to be clarified. As with the data they obtained using the recombinant PAWP protein, it will be important for other groups to independently investigate these specific claims for the potent inhibitory effects of these PAWP-derived proline-rich peptides, since these claims have important implications for our understanding of the mechanism of Ca 2+ release at fertilization. It is worthwhile to reflect that over the last few decades there have been various sperm-derived molecules implicated in activating the oocyte by causing Ca 2+ release. These previous "sperm factor" candidates include a 33 kDa protein, 13 nitric oxide, 14 and tr-kit, a truncated form of the c-kit receptor. 15 None of these molecules stood the test of time, mainly because subsequent research either could not validate or else did not build upon, the original data. In contrast, when PLCζ was first shown to cause Ca 2+ oscillations in mouse oocytes, two independent verification and extensions of the original findings were reported within 2 years. 6, 16 In the following decade, many other groups have confirmed that PLCζ causes Ca 2+ oscillations in oocytes from a range of different species ( Table 1) . 3 Interestingly, immunolocalization analysis has indicated that PLCζ, like PAWP, is also present in the perinuclear matrix of the sperm. 16 At present, unfortunately, there remains no published data from mouse "knockout" models for either PLCζ or PAWP. The availability of such mice should provide the conclusive evidence of a direct physiological role for these mammalian sperm proteins in the Ca 2+ signaling that is essential for oocyte activation.
So despite the intriguing new data presented in the paper by Aarabi et al. 9 there is a need for further independent verification of these important results so that PAWP can then also be considered a candidate for the "real" sperm factor, which mobilizes the physiological Ca 2+ signal that triggers oocyte activation and early embryo development.
